PCA
GMED icon

Pallas Capital Advisors’s Globus Medical GMED Stock Holding History

Pallas Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,839
Closed -$1.27M – 276
2023
Q1 		$1.27M Sell
21,839
-193
-0.9% -$12.4K 0.12% 124
2022
Q4 		$1.63M Buy
22,032
+511
+2% +$34.8K 0.17% 104
2022
Q3 		$1.39M Buy
21,521
+1,164
+6% +$70.1K 0.15% 104
2022
Q2 		$1.15M Buy
20,357
+1,826
+10% +$120K 0.16% 113
2022
Q1 		$1.44M Buy
18,531
+3,182
+21% +$221K 0.18% 99
2021
Q4 		$1.04M Buy
15,349
+723
+5% +$52.5K 0.13% 122
2021
Q3 		$1.14M Buy
14,626
+3,501
+31% +$281K 0.13% 138
2021
Q2 		$897K Buy
11,125
+1,202
+12% +$85.5K 0.13% 127
2021
Q1 		$705K Buy
+9,923
New +$628K 0.16% 109

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Pallas Capital Advisors's GMED Position: Q2 2023 in Review

Pallas Capital Advisors sold out of Globus Medical (GMED) in Q2 2023, closing a stake of 21,839 shares — an estimated $1.27M sold.

Pallas Capital Advisors first reported a position in GMED in Q1 2021 and held it in 9 quarters. The position peaked at $1.63M in Q4 2022. 382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • Pallas Capital Advisors reported no remaining Globus Medical position as of Q2 2023 after selling out during the quarter.
  • Pallas Capital Advisors sold 21,839 Globus Medical shares in Q2 2023, an estimated $1.27M.
  • Pallas Capital Advisors first reported a position in Globus Medical in Q1 2021 and held it in 9 quarters.
  • Pallas Capital Advisors's Globus Medical position peaked at $1.63M in Q4 2022.
  • 382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on Pallas Capital Advisors's 13F filing for Q2 2023, filed 26 Jul 2023.